Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Thornton

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the Medical Association of the State of Alabama|February 1, 1981
A case of Kawasaki's disease appearing as staphylococcal scalded-skin syndromeR B Thornton, S E Gaskins
Journal of Biomedical Engineering|July 1, 1984
The lifting stress calculatorF J Bejjani, K A Josephson, R B Thornton
International Journal of Pediatric Otorhinolaryngology|January 12, 2024
Safety, tolerability, and effect of a single aural dose of Dornase alfa at the time of ventilation tube surgery for otitis media: A Phase 1b double randomized control trialR B Thornton, S Jeffares, E Seppanen, et al.
International Journal of Pediatric Otorhinolaryngology|December 28, 2019
Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019R B Thornton, A Hakansson, D W Hood, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 12, 2007
Distinctive immunoglobulin E anti-house dust allergen-binding specificities in a tropical Australian Aboriginal communityB J Hales, I A Laing, L J Pearce, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
The Journal of Infection|November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the Medical Association of the State of Alabama|February 1, 1981
A case of Kawasaki's disease appearing as staphylococcal scalded-skin syndromeR B Thornton, S E Gaskins
Journal of Biomedical Engineering|July 1, 1984
The lifting stress calculatorF J Bejjani, K A Josephson, R B Thornton
International Journal of Pediatric Otorhinolaryngology|January 12, 2024
Safety, tolerability, and effect of a single aural dose of Dornase alfa at the time of ventilation tube surgery for otitis media: A Phase 1b double randomized control trialR B Thornton, S Jeffares, E Seppanen, et al.
International Journal of Pediatric Otorhinolaryngology|December 28, 2019
Panel 7 - Pathogenesis of otitis media - a review of the literature between 2015 and 2019R B Thornton, A Hakansson, D W Hood, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 12, 2007
Distinctive immunoglobulin E anti-house dust allergen-binding specificities in a tropical Australian Aboriginal communityB J Hales, I A Laing, L J Pearce, et al.
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
The Journal of Infection|November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Pageof 1